양극성장애로 오인된 LGI1 자가면역성뇌염

Leucine rich glioma inactivated (LGI1) encephalitis is an uncommon neurological disorder rarely encountered in clinical practice. However, it is a potentially fatal autoimmune syndrome that can decrease the level of consciousness, possibly progressing to coma. Additionally, unless diagnosed and prom...

Full description

Saved in:
Bibliographic Details
Published inJournal of the Korean Society of Biological Psychiatry Vol. 27; no. 2; pp. 112 - 116
Main Authors 김은수, 이희준, 전상원, 조성준, Kim, Eun Soo, Lee, HeeJun, Jeon, Sang Won, Cho, Sung Joon
Format Journal Article
LanguageKorean
Published 대한생물정신의학회 01.10.2020
Subjects
Online AccessGet full text
ISSN1225-8709
2005-7571
DOI10.22857/kjbp.2020.27.2.009

Cover

More Information
Summary:Leucine rich glioma inactivated (LGI1) encephalitis is an uncommon neurological disorder rarely encountered in clinical practice. However, it is a potentially fatal autoimmune syndrome that can decrease the level of consciousness, possibly progressing to coma. Additionally, unless diagnosed and promptly treated, it can cause permanent cognitive impairment. Since LGI1 encephalitis can initially present with psychiatric symptoms, there can be delays in reaching a proper diagnosis. This report describes a case of a 47-year-old woman with LGI1 antibodies-associated limbic encephalitis who initially presented with psychosis. Her blood tests were normal and no MRI and EEG abnormalities were found. Cerebrospinal fluid analysis was negative for other possible infectious causes. Three months after admission, she was found to be LGI1 antibody positive. LGI1 encephalitis should be suspected in patients with symptoms such as memory loss, confusion, seizures, and psychiatric symptoms. Prompt diagnosis and treatment of LGI1 encephalitis are warranted because prognosis becomes worse when such actions are delayed.
Bibliography:KISTI1.1003/JNL.JAKO202023563781588
ISSN:1225-8709
2005-7571
DOI:10.22857/kjbp.2020.27.2.009